Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 75.32
+1.84 (2.50%)
Apr 24, 2025, 2:45 PM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 23, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 30,510 | 29,847 | 21,296 | 15,837 | 11,911 | 13,872 | Upgrade
|
| Market Cap Growth | 40.15% | 40.15% | 34.47% | 32.96% | -14.13% | - | Upgrade
|
| Enterprise Value | 29,710 | 29,272 | 20,670 | 15,360 | 11,446 | 13,419 | Upgrade
|
| Last Close Price | 75.00 | 73.37 | 51.97 | 38.45 | 28.81 | 33.50 | Upgrade
|
| PE Ratio | 34.76 | 36.06 | 38.34 | 55.18 | 65.73 | 119.00 | Upgrade
|
| Forward PE | 25.89 | 28.12 | 28.12 | 28.12 | 28.12 | 64.34 | Upgrade
|
| PS Ratio | 10.36 | 10.60 | 10.14 | 10.37 | 10.52 | 17.47 | Upgrade
|
| PB Ratio | 11.10 | 11.69 | 11.35 | 11.25 | 10.26 | 13.87 | Upgrade
|
| P/TBV Ratio | 11.80 | 12.53 | 12.64 | 12.32 | 11.74 | 16.75 | Upgrade
|
| P/FCF Ratio | 93.57 | 166.48 | 95.23 | 109.98 | 271.61 | - | Upgrade
|
| P/OCF Ratio | 54.61 | 69.31 | 41.59 | 43.61 | 50.73 | 149.79 | Upgrade
|
| EV/Sales Ratio | 10.09 | 10.39 | 9.84 | 10.06 | 10.11 | 16.90 | Upgrade
|
| EV/EBITDA Ratio | 27.13 | 28.25 | 29.03 | 38.09 | 43.97 | 81.31 | Upgrade
|
| EV/EBIT Ratio | 29.27 | 30.27 | 31.32 | 42.66 | 51.64 | 105.77 | Upgrade
|
| EV/FCF Ratio | 91.12 | 163.28 | 92.42 | 106.67 | 260.99 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.05 | 0.04 | 0.07 | 0.57 | - | Upgrade
|
| Asset Turnover | 1.04 | 1.04 | 1.02 | 0.96 | 0.87 | 0.80 | Upgrade
|
| Inventory Turnover | 0.82 | 0.82 | 0.90 | 1.39 | 1.18 | 1.01 | Upgrade
|
| Quick Ratio | 3.55 | 3.55 | 2.80 | 3.04 | 4.01 | 5.76 | Upgrade
|
| Current Ratio | 4.34 | 4.34 | 3.32 | 3.57 | 4.71 | 6.72 | Upgrade
|
| Return on Equity (ROE) | 37.37% | 37.37% | 33.83% | 22.35% | 16.77% | 14.91% | Upgrade
|
| Return on Assets (ROA) | 22.36% | 22.36% | 19.99% | 14.09% | 10.59% | 8.00% | Upgrade
|
| Return on Capital (ROIC) | 27.19% | 27.19% | 24.98% | 17.29% | 12.56% | 9.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 36.80% | 36.80% | 33.80% | 24.00% | 17.80% | 11.80% | Upgrade
|
| Earnings Yield | 2.89% | 2.77% | 2.61% | 1.81% | 1.52% | 0.84% | Upgrade
|
| FCF Yield | 1.07% | 0.60% | 1.05% | 0.91% | 0.37% | -0.19% | Upgrade
|
| Dividend Yield | 0.56% | - | 0.79% | 0.55% | 0.35% | 0.15% | Upgrade
|
| Payout Ratio | 18.95% | 20.15% | 15.60% | 14.17% | 11.41% | 10.91% | Upgrade
|
| Buyback Yield / Dilution | -0.56% | -0.56% | -0.29% | -0.39% | -0.18% | -12.54% | Upgrade
|
| Total Shareholder Return | 0.00% | -0.56% | 0.50% | 0.16% | 0.17% | -12.39% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.